A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 228,808 shares of AIM stock, worth $57,202. This represents 0.0% of its overall portfolio holdings.

Number of Shares
228,808
Previous 220,808 3.62%
Holding current value
$57,202
Previous $104,000 19.23%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.35 - $0.61 $2,800 - $4,880
8,000 Added 3.62%
228,808 $84,000
Q1 2024

May 13, 2024

BUY
$0.33 - $0.48 $6,204 - $9,024
18,800 Added 9.31%
220,808 $104,000
Q4 2023

Feb 13, 2024

BUY
$0.4 - $0.56 $3,880 - $5,432
9,700 Added 5.04%
202,008 $89,000
Q3 2023

Nov 14, 2023

BUY
$0.44 - $0.71 $5,940 - $9,585
13,500 Added 7.55%
192,308 $88,000
Q2 2023

Aug 11, 2023

BUY
$0.4 - $0.67 $4,040 - $6,767
10,100 Added 5.99%
178,808 $120,000
Q1 2023

May 12, 2023

BUY
$0.32 - $0.77 $10,176 - $24,486
31,800 Added 23.23%
168,708 $73,000
Q4 2022

Feb 13, 2023

BUY
$0.31 - $0.6 $3,720 - $7,200
12,000 Added 9.61%
136,908 $43,000
Q3 2022

Nov 14, 2022

BUY
$0.57 - $0.81 $2,565 - $3,645
4,500 Added 3.74%
124,908 $73,000
Q2 2022

Aug 12, 2022

SELL
$0.78 - $1.27 $239,977 - $390,732
-307,663 Reduced 71.87%
120,408 $94,000
Q1 2022

May 13, 2022

SELL
$0.67 - $1.18 $185,609 - $326,894
-277,029 Reduced 39.29%
428,071 $454,000
Q4 2021

Feb 11, 2022

BUY
$0.92 - $1.96 $648,692 - $1.38 Million
705,100 New
705,100 $649,000
Q3 2021

Nov 12, 2021

SELL
$1.91 - $2.17 $291,939 - $331,680
-152,848 Closed
0 $0
Q2 2021

Aug 13, 2021

SELL
$1.93 - $2.39 $629,008 - $778,927
-325,911 Reduced 68.07%
152,848 $329,000
Q1 2021

May 13, 2021

BUY
$1.88 - $2.82 $900,066 - $1.35 Million
478,759 New
478,759 $1.09 Million
Q1 2020

May 14, 2020

SELL
$0.56 - $6.1 $9,688 - $105,530
-17,300 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$0.39 - $0.71 $6,747 - $12,283
17,300 New
17,300 $9,000

Others Institutions Holding AIM

About AIM ImmunoTech Inc.


  • Ticker AIM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,049,300
  • Market Cap $12M
  • Description
  • AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...
More about AIM
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.